β₂-Adrenoceptor Polymorphisms Predict Response to β₂-Agonists in Children with Acute Asthma

References

• Koga T, Kamimura T, Oshita Y, Narita Y, Mukaino T, Nishimura M, Mizoguchi Y, Aizawa H. Determinants of bronchodilator responsiveness in patients with controlled asthma. J Asthma 2006; 43(1)71–74
   PubMed Web of Science ®Google Scholar
• Tsai H J, Shaikh N, Kho J Y, Battle N, Naqvi M, Navarro D, Matallana H, Lilly C M, Eng C S, Kumar G, Thyne S, Watson H G, Meade K, Lenoir M, Choudhry S, Burchard E G. beta(2)-Adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Hum Genet 2006; 119(5)547–557
   PubMed Web of Science ®Google Scholar
• Ramsay C E, Hayden C M, Tiller K J, Burton P R, Goldblatt J, Lesouef P N. Polymorphisms in the beta2-adrenoreceptor gene are associated with decreased airway responsiveness. Clin Exp Allergy 1999; 29(9)1195–1203
   Google Scholar
• Turki J, Pak J, Green S A, Martin R J, Liggett S B. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95(4)1635–1641
   PubMed Web of Science ®Google Scholar
• Hall I P, Wheatley A, Wilding P, Liggett S B. Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995; 345(8959)1213–1214
   Google Scholar
• Weir T D, Mallek N, Sandford A J, Bai T R, Awadh N, Fitzgerald J M, Cockcroft D, James A, Liggett S B, Pare P D. beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998; 158(3)787–791
   Google Scholar
• Contopoulos-Ioannidis D G, Manoli E N, Ioannidis J P. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005; 115(5)963–972
   Google Scholar
• Joos L, Sandford A J. Genotype predictors of response to asthma medications. Curr Opin Pulm Med 2002; 8(1)9–15
   Google Scholar
• Johnson M. The beta-adrenoceptor. Am J Respir Crit Care Med 1998; 158(5 Pt 3)S146–S153
   PubMed Web of Science ®Google Scholar
• Reihsaus E, Innis M, MacIntyre N, Liggett S B. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8(3)334–339
   PubMed Web of Science ®Google Scholar
• Hall I P, Blakey J D, Al Balushi K A, Wheatley A, Sayers I, Pembrey M E, Ring S M, McArdle W L, Strachan D P. Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study. Lancet 2006; 368(9537)771–779
   Google Scholar
• Green S A, Turki J, Bejarano P, Hall I P, Liggett S B. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13(1)25–33
   PubMed Web of Science ®Google Scholar
• Chong L K, Chowdry J, Ghahramani P, Peachell P T. Influence of genetic polymorphisms in the beta2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics 2000; 10(2)153–162
   Google Scholar
• Joos L, Pare P D, Sandford A J. beta(2)-Adrenergic receptor polymorphisms and asthma. Curr Opin Pulm Med 2001; 7(2)69–74
   Google Scholar
• Martin A C, Laing I A, Khoo S K, Zhang G, Rueter K, Teoh L, Taheri S, Hayden C M, Geelhoed G C, Goldblatt J, LeSouef P N. Acute asthma in children: Relationships among CD14 and CC16 genotypes, plasma levels, and severity. Am J Respir Crit Care Med 2006; 173(6)617–622
   Google Scholar
• Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998; 339(15)1030–1035
   PubMed Web of Science ®Google Scholar
• National Asthma Council of Australia. 2002
   Google Scholar
• Miller S A, Dykes D D, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3)1215
   PubMed Web of Science ®Google Scholar
• Holloway J W, Dunbar P R, Riley G A, Sawyer G M, Fitzharris P F, Pearce N, Le Gros G S, Beasley R. Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy 2000; 30(8)1097–1103
   Google Scholar
• Stephens M, Smith N J, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68(4)978–989
   PubMed Web of Science ®Google Scholar
• SPSS Inc. SPSS for Windows. Release 11. Chicago, Illinois 2001
   Google Scholar
• Browne G J, Penna A S, Phung X, Soo M. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet 1997; 349(9048)301–305
   PubMed Web of Science ®Google Scholar
• Yung M, South M. Randomised controlled trial of aminophylline for severe acute asthma. Arch Dis Child 1998; 79(5)405–410
   PubMed Web of Science ®Google Scholar
• Ciarallo L, Sauer A H, Shannon M W. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. J Pediatr 1996; 129(6)809–814
   PubMed Web of Science ®Google Scholar
• Roberts G, Newsom D, Gomez K, Raffles A, Saglani S, Begent J, Lachman P, Sloper K, Buchdahl R, Habel A. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. Thorax 2003; 58(4)306–310
   PubMed Web of Science ®Google Scholar
• Martinez F D, Graves P E, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100(12)3184–3188
   PubMed Web of Science ®Google Scholar
• Israel E, Chinchilli V M, Ford J G, Boushey H A, Cherniack R, Craig T J, Deykin A, Fagan J K, Fahy J V, Fish J, Kraft M, Kunselman S J, Lazarus S C, Lemanske R F, Jr., Liggett S B, Martin R J, Mitra N, Peters S P, Silverman E, Sorkness C A, Szefler S J, Wechsler M E, Weiss S T, Drazen J M. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004; 364(9444)1505–1512
   PubMed Web of Science ®Google Scholar
• Wechsler M E, Lehman E, Lazarus S C, Lemanske R F, Jr., Boushey H A, Deykin A, Fahy J V, Sorkness C A, Chinchilli V M, Craig T J, DiMango E, Kraft M, Leone F, Martin R J, Peters S P, Szefler S J, Liu W, Israel E. beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006; 173(5)519–526
   PubMed Web of Science ®Google Scholar
• Litonjua A A. The significance of beta2-adrenergic receptor polymorphisms in asthma. Curr Opin Pulm Med 2006; 12(1)12–17
   Google Scholar
• Salpeter S R, Buckley N S, Ormiston T M, Salpeter E E. Meta-Analysis: Effect of Long-Acting {beta}-Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths. Ann Intern Med 2006
   Google Scholar
• Telleria J J, Blanco-Quiros A, Muntion S, Antonio Garrote J, Arranz E, Armentia A, Diez I, Castro J. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms. Respir Med 2006; 100(6)1072–1078
   Google Scholar
• Wechsler M E, Israel E. How pharmacogenomics will play a role in the management of asthma. Am J Respir Crit Care Med 2005; 172(1)12–18
   Google Scholar